For older people, medications are common; AGS Beers Criteria aims to make them appropriate, too

by American Geriatrics Society

The American Geriatrics Society (AGS) today unveiled its latest update to one of geriatrics' most frequently cited reference tools: The AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. With more than 90% of older people using at least one prescription and more than 66% using three or more in any given month, the AGS Beers Criteria—a compendium of medications potentially to avoid or consider with caution because they often present an unfavorable balance of benefits and harms for older people—plays a vital role in helping health professionals, older adults, and caregivers work together to ensure medications are appropriate.

05 feb 2019--"Medications play an important role in health and wellbeing for many older people," noted Donna M. Fick, Ph.D., RN, FGSA, FAAN, a co-chair of the expert panel responsible for the 2019 AGS Beers Criteria. "With this new update, we hope the latest information on what makes medications appropriate for older people can play an equally important role in decisions about treatment options that meets the needs of older adults while also keeping them as safe as possible."

Published in its entirety in the Journal of the American Geriatrics Society, the AGS Beers Criteria also includes a host of resources— from mobile apps to a pocket reference card—to help clinicians implement prescribing recommendations (available from GeriatricsCareOnline.org), as well as tools to aid older adults and caregivers in understanding what "potentially inappropriate" medications mean (available for free from HealthinAging.org).

What is the AGS Beers Criteria?

The AGS Beers Criteria includes lists of certain medications worth discussing with health professionals because they may not be the safest or most appropriate options for older adults. Though not an exhaustive catalogue of inappropriate treatments, the five lists included in the AGS Beers Criteria describe particular medications with evidence suggesting they should be:

1. Avoided by most older people (outside of hospice and palliative care settings);
2. Avoided by older people with specific health conditions;
3. Avoided in combination with other treatments because of the risk for harmful "drug-drug" interactions;
4. Used with caution because of the potential for harmful side effects; or
5. Dosed differently or avoided among people with reduced kidney function, which impacts how the body processes medicine.

First developed by Mark Beers, MD, and colleagues in 1991, these lists have been staples of care for nearly three decades. They were transitioned to the AGS—a nonprofit society of some 6,000 experts in care for older people—in 2011.

What's new in 2019?

A panel of 13 experts reviewed more than 1,400 clinical trials and research studies published between 2017 and the last update in 2015. Across its five lists, the 2019 AGS Beers Criteria includes:

• 30 individual medications or medication classes to avoid for most older people.
• 40 medications or medication classes to use with caution or avoid when someone lives with certain diseases or conditions.
• Several changes to medications previously identified as potentially inappropriate. Twenty-five medications or medication classes were dropped outright from the last update to the AGS Beers Criteria in 2015, while several others were moved to new categories or had guidance revised based on new evidence.

Companion tools released with the 2019 update also include an expanded editorial outlining the proper use of the AGS Beers Criteria, particularly when it comes to two important priorities this tool helps shape: Safe prescribing practices at the bedside and the development of quality measures for evaluating health care.

"The AGS Beers Criteria aims to guide older people and health professionals away from potentially harmful treatments while helping us assess quality of care," noted Todd Semla, MS, PharmD, BCGP, FCCP, AGSF, also a co-chair of the AGS Beers Criteria panel for 2019.

"The AGS Beers Criteria should never solely dictate how medications are prescribed, nor should it justify restricting health coverage. This tool works best as a starting point for a discussion—one guided by personal needs and priorities as we age," added Michael Steinman, MD, a fellow co-chair of the AGS Beers Criteria panel.

In support of this principle, the AGS Beers Criteria panelists used their companion editorial (DOI: 10.111/jgs.15766) to reiterate that:

• Potentially inappropriate medications are just that—potentially inappropriate. They merit special scrutiny but should not be misconstrued as universally unacceptable in all cases or for all people.
• The caveats and rationales informing AGS Beers Criteria recommendations are as important as the recommendations themselves. Appreciating these nuances can help healthcare professionals know why medications are included on the lists, and how approaches to prescribing can be adjusted accordingly.

Remember: Never change or discontinue treatment without speaking to a health professional first. 

Visit GeriatricsCareOnline.org or HealthinAging.org for more info on medication use and the AGS Beers Criteria.

More information: , American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults, Journal of the American Geriatrics Society (2019).DOI: 10.1111/jgs.15767

Provided by American Geriatrics Society

American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

04 may 2012--Potentially inappropriate medications (PIMs) continue to be prescribed and used as  first-line treatment for the most vulnerable of older adults, despite evidence of poor outcomes from the use of PIMs in older adults. PIMs now form an integral part of policy and practice and are incorporated into several quality measures.

The specific aim of this project was to update the previous Beers Criteria using a comprehensive, systematic review and grading of the evidence on drug-related problems and adverse drug events (ADEs) in older adults. This was accomplished through the support of The American Geriatrics Society (AGS) and the work of an interdisciplinary panel of 11 experts in geriatric care and pharmacotherapy who applied a modi- fied Delphi method to the systematic review and grading to reach consensus on the updated 2012 AGS Beers Criteria.

Fifty-three medications or medication classes encompass the final updated Criteria, which are divided into three categories: potentially inappropriate medications and classes to avoid in older adults, potentially inappropriate medications and classes to avoid in older adults with certain diseases and syndromes that the drugs listed can exacerbate, and finally medications to be used with caution in older adults.

This update has much strength, including the use of an evidence-based approach using the Institute of Medicine standards and the development of a partnership to regularly update the Criteria. Thoughtful application of the Criteria will allow for (a) closer monitoring of drug use, (b) application of real-time e-prescribing and interventions to decrease ADEs in older adults, and (c) better patient outcomes.